Los Angeles, California, United States
I love exploring the world of technology, trying to make sense of it, identifying what's being disrupted, who the key disruptors are, and where value is either being created or destroyed. If I were a professor, I'd teach this as a class; if I were an author, I'd write a book about it. But as an investor, my job is to wake up every day and study the most fascinating trends, people, and technologies. Sometimes, I come across an asymmetric opportunity—where I feel I understand something just a little better—and on the venture side, I’m fortunate enough to partner with world-class founders and teams, owning part of the company and being part of that long journey. On the public side, it's a similar experience, often being a participant in long-term growth stories Key Influences *Management -- Jim Collins *Business as Life -- Richard Branson *Investing -- Peter Lynch *Tenacity and Vision -- Steve Jobs *Coaching -- John Wooden *Invention -- Elon Musk *Tech Innovation -- Andy Grove *Adventure -- my friends *Relaxation -- Backyard workouts! *Zen - -My daughters *Bliss -- My wife
Institutional-quality research covering AI infrastructure, semiconductors, and optical interconnects. Focused on silicon architecture, co-design strategy, and capital allocation frameworks across the AI compute stack. Readership includes portfolio managers, semiconductor engineers, and technology investors at leading hedge funds, family offices, and asset managers.
Terray exists to change the way experimentation and computation work together. We believe high-quality data at scale is the key to unlocking generative AI for small molecules. Our workflow places equal emphasis on wet lab science and AI, giving us everything we need to solve the toughest therapeutic challenges.
The Terasaki Institute for Biomedical Innovation envisions a world where personalized medicine is available to all. Every person is unique with individual challenges to optimal health, from genetic predisposition to disease to socioeconomic barriers to care. We strive to address those challenges to bridge the gap between sickness and wellness. The Terasaki Institute for Biomedical Innovation aims to tackle the biggest problems in health. We are focused on solving problems in new ways, developing ‘personalized’ solutions, prototyping tangible solutions, and bringing our innovation to the real-world.
Omeat is a food startup that has pioneered a scalable way to produce cultivated meat that’s delicious, affordable, orders-of-magnitude more sustainable than conventional meat, and doesn’t involve sacrificing an animal. The secret to Omeat is a proprietary process that harnesses the intrinsically regenerative factors within cows' plasma to foster cell growth. Omeat’s growth media is a cost-effective alternative to fetal bovine serum and can be used to cultivate any kind of meat. Omeat is based in Los Angeles, founded in 2020 by world-renown tissue biologist Dr. Ali Khademhosseini. The company is currently building a pilot plant and rapidly expanding its team toward commercial readiness.